Daptomycin (Cubicin) in patients with complicated skin or soft-tissue infections

Daptomycin (Cubicin) in patients with complicated skin or soft-tissue infections

Skin and soft-tissue infections (SSTIs) are commonly observed and differ in terms of site and localization, clinical characteristics, and the aetiological agent; these infections are usually caused by Staphylococcus aureus or beta-haemolytic streptococci, and are the most frequent forms of methicill...

Full description

Bibliographic Details
Main Author:	Viola Sacchi
Format:	Article
Language:	English
Published:	SEEd Medical Publishers 2008-09-01
Series:	Farmeconomia: Health Economics and Therapeutic Pathways
Online Access:	https://journals.seedmedicalpublishers.com/index.php/FE/article/view/229

Similar Items

Complicated skin and soft tissue infections: literature review of evidence for and experience with daptomycin
by: White B, et al.
Published: (2011-05-01)

The Efficacy and Safety of High-dose Daptomycin in the Treatment of Complicated Skin and Soft Tissue Infections in Asians
by: Xiao-meng Dong, et al.
Published: (2020-06-01)

Treatment of complicated skin and soft-tissue infections caused by resistant bacteria: value of linezolid, tigecycline, daptomycin and vancomycin
by: Eckmann Christian, et al.
Published: (2010-11-01)

The Effects of Azithromycin and Cubicin on the Murine Immune Response
by: Carrier, Jessica M.
Published: (2017)

Efficacy and safety of daptomycin for skin and soft tissue infections: a systematic review with trial sequential analysis
by: Liu C, et al.
Published: (2016-09-01)

Pharmacokinetics and skin-tissue penetration of daptomycin in rats
by: Matsumoto K, et al.
Published: (2015-05-01)

Economic burden of inpatient and outpatient antibiotic treatment for methicillin-resistant Staphylococcus aureus complicated skin and soft-tissue infections: a comparison of linezolid, vancomycin, and daptomycin
by: Stephens JM, et al.
Published: (2013-09-01)

In vitro susceptibility of methicillin-resistant Staphylococcus aureus isolates from skin and soft tissue infections to vancomycin, daptomycin, linezolid and tedizolid
by: Johanna Marcela Vanegas Múnera, et al.
Published: (2017-09-01)

Dalbavancin in the treatment of complicated skin and soft-tissue infections: a review
by: Jason W Bennett, et al.
Published: (2008-03-01)

Daptomycin: Local Application in Implant-Associated Infection and Complicated Osteomyelitis
by: Steffen B. Rosslenbroich, et al.
Published: (2012-01-01)

Complicated skin, skin structure and soft tissue infections - are we threatened by multi-resistant pathogens?
by: Kujath P, et al.
Published: (2010-11-01)

Ceftaroline in the management of complicated skin and soft tissue infections and community acquired pneumonia
by: Mpenge MA, et al.
Published: (2015-04-01)

Telavancin, a new lipoglycopeptide antimicrobial, in complicated skin and soft tissue infections
by: Lida Jafari Saraf, et al.
Published: (2011-03-01)

Daptomycin exposure precedes infection and/or colonization with daptomycin non-susceptible enterococcus
by: Storm Jeremy C, et al.
Published: (2012-05-01)

Skin and Soft Tissue Infections in Patients with Solid Tumours
by: Diamantis P. Kofteridis, et al.
Published: (2012-01-01)

Complicated Posterior Cervical Skin and Soft Tissue Infections at a Single Referral Center
by: Jing-Chun Zhao, et al.
Published: (2020-01-01)

Comparative pharmacoeconomic analysis of ceffaroline fosamil in the treatment of complicated skin and soft tissues infections
by: S. K. Zyryanov, et al.
Published: (2018-05-01)

A Rare Agent in the Etiology of Complicated Skin and Soft Tissue Infection: Raoultella Planticola
by: Meltem IŞIKGÖZ TAŞBAKAN, et al.
Published: (2014-12-01)

Retrospective Analysis of Clinical and Cost Outcomes Associated with Methicillin-Resistant Staphylococcus aureus Complicated Skin and Skin Structure Infections Treated with Daptomycin, Vancomycin, or Linezolid
by: Bradley M. Wright, et al.
Published: (2011-01-01)

Purulent Skin and Soft Tissue Infection
by: Steven Alexander Kahn MD, et al.
Published: (2010-10-01)

Daptomycin in the treatment of infective endocarditis
by: Popov D.A.
Published: (2018-02-01)

Management of complicated skin and soft tissue infections with a special focus on the role of newer antibiotics
by: Leong HN, et al.
Published: (2018-10-01)

Skin and soft tissue infection by Mycobacterium intracellulare in an immunocompetent patient
by: Alessio Pampaloni, et al.
Published: (2020-01-01)

The Prevalence of S. aureus Skin and Soft Tissue Infections in Patients with Pemphigus
by: Zeinab Fagheei Aghmiyuni, et al.
Published: (2016-01-01)

Are Blood Cultures Useful in Patients with Skin and Soft Tissue Infections?
by: İlkay BOZKURT
Published: (2018-12-01)

Dalbavancin in the treatment of skin and soft tissues infection
by: Ana Candela Fajardo, et al.
Published: (2017-09-01)

Dalbavancin in the treatment of skin and soft tissue infections
by: Nikulin A.A., et al.
Published: (2018-11-01)

Topical Antiseptic Formulations for Skin and Soft Tissue Infections
by: Thi Phuong Nga Hoang, et al.
Published: (2021-04-01)

Bone penetration of daptomycin in diabetic patients with bacterial foot infections
by: Antoine Grillon, et al.
Published: (2019-08-01)

Daptomycin treatment in patients with resistant staphylococcal periprosthetic joint infection
by: Yu-Jui Chang, et al.
Published: (2017-11-01)

Epidemiology and Outcomes of Complicated Skin and Soft Tissue Infections among Inpatients in Southern China from 2008 to 2013.
by: Xiaoyan Li, et al.
Published: (2016-01-01)

Tedizolid – a new antibiotic to solve old problems: prospects for the treatment of complicated skin and soft tissue infections
by: A. V. Rodin, et al.
Published: (2019-04-01)

Potential of the Introduction of Tedizolid for the Treatment of Complicated Skin and Soft Tissue Infections in a Russian Multi-Field Hospital
by: Belkova Yu.А., et al.
Published: (2016-08-01)

De Novo Daptomycin-Nonsusceptible Enterococcal Infections
by: Theodoros Kelesidis, et al.
Published: (2012-04-01)

Treatment Failure Outcomes for Emergency Department Patients with Skin and Soft Tissue Infections
by: Larissa S. May, et al.
Published: (2015-10-01)

High MICs for Vancomycin and Daptomycin and Complicated Catheter-Related Bloodstream Infections with Methicillin-Sensitive Staphylococcus aureus
by: Rafael San-Juan, et al.
Published: (2016-06-01)

A prospective, multicenter, observational study of complicated skin and soft tissue infections in hospitalized patients: clinical characteristics, medical treatment, and outcomes
by: Lipsky Benjamin A, et al.
Published: (2012-09-01)

Early switch/early discharge opportunities for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections in Brazil
by: Guilherme H. Furtado, et al.
Published: (2019-03-01)

Skin and soft tissue infections and associated complications among commercially insured patients aged 0-64 years with and without diabetes in the U.S.
by: Jose A Suaya, et al.
Published: (2013-01-01)

Community-Associated Methicillin-Resistant Skin and Soft Tissue Infections
by: Limin Wijaya MBBS, MRCP, DTMH, et al.
Published: (2010-09-01)

Cannot write session to /tmp/vufind_sessions/sess_89nl628tdrhepeu6hge9jh8cl3